Kessler Topaz Meltzer & Check, LLP reminds shareholders of Kyverna Therapeutics, Inc. on the deadline for the Investing.com securities fraud class action lawsuit
Radnor, Pennsylvania–(Newsfile Corp. – January 3, 2025) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that against Kyverna Therapeutics, Inc. . (“Kyverna”) (NASDAQ: KYTX) on behalf of those who purchased Kyverna common stock pursuant to and/or subsequent to Kyverna’s February 8, 2024 initial public offering (“IPO”). The deadline for the chief prosecutor is February 7, 2025.
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you suffered losses in Kyverna, you can CLICK HERE or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
You may also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at info@ktmc.com.
ALLEGED GOOD BEHAVIOR OF THE ACCUSED:
The complaint alleges that in the prospectus and registration statements issued in connection with the IPO, the defendants made materially false and/or misleading statements and/or omissions regarding the company’s business, operations and prospects. Specifically, Defendants made false and/or misleading statements regarding, and/or failed to disclose, that Kyverna possessed negative data regarding one of its clinical trials at the time of its IPO.
PROCEDURE OF THE CHIEF PROSECUTOR:
Kyverna investors can, no later than February 7, 2025. seek to be appointed as lead class plaintiff representative through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. The lead plaintiff is the representative party that acts on behalf of all class members in the conduct of the litigation. The lead plaintiff is usually an investor or a small group of investors who have the greatest financial interest and who are also appropriate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and those attorneys, if approved by the court, are lead or class counsel. The decision whether or not to be the lead plaintiff does not affect your ability to participate in the recovery.
Kessler Topaz Meltzer & Check, LLP encourages Kyverna investors who have suffered significant losses to contact the firm directly for more information.
CLICK HERE TO APPLY FOR THE CASE OR COPY AND PASTE THIS LINK INTO YOUR BROWSER: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP litigates class actions in state and federal courts nationwide and around the world. The company has built a global reputation for excellence and has recovered billions of dollars from victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by companies and fiduciaries. The appeal in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP, visit www.ktmc.com.
CONTACT:
May be considered solicitor advertising in certain jurisdictions. Past results do not guarantee future results.
To view the original version of this press release, visit https://www.newsfilecorp.com/release/235393
